Biro · Heliyon 2018 · In vitro isolation/synthesis and controlled animal experiment · n=?

Isolation of allithiamine from Hungarian red sweet pepper seed ( Capsicum annuum L. ).

Cited 9 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical laboratory phytochemistry and animal model study

PubMed 30582034 · doi:10.1016/j.heliyon.2018.e00997 · record verified 2026-08-29

What was done

Researchers developed extraction (96% ethanol solid-liquid extraction followed by C18 solid-phase extraction) and chemical synthesis methods to obtain allithiamine from Hungarian red sweet pepper (*Capsicum annuum*) seeds. The compound structure was verified using reverse-phase HPLC, HPLC-MS, MALDI-TOF MS, and NMR. The functional effect of allithiamine on neuropathic pain was then evaluated in streptozotocin-induced diabetic mice, using benfothiamine as a comparator.

What was found

Allithiamine was confirmed as a constituent of sweet pepper seeds. In diabetic neuropathic mice, treatment with allithiamine improved neuropathic pain sensation with an efficacy reported as similar to benfothiamine. The abstract reports no numerical values, dosages, or statistical effect sizes.

Why it matters

This identifies sweet pepper seeds as the first non-*Allium* natural source of allithiamine and demonstrates preclinical proof-of-concept for its potential utility in diabetic neuropathy.

Limits

Findings are limited to animal and laboratory models and cannot establish clinical efficacy or safety in humans. The abstract does not state the number of animals tested, the treatment doses, or the specific quantitative outcomes of the pain assays.

Cited by